Board of Bliss GVS Pharma recommends interim dividend Back
Bliss GVS Pharma announced that the Board of Directors of the Company at its meeting held on 10 February 2026, inter alia, have recommended the interim dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.